Sales & Earnings In Brief
This article was originally published in The Rose Sheet
Executive Summary
J&J results: Skin care is Johnson & Johnson's fastest growing consumer business and second largest consumer segment, Chairman and CEO William Weldon reports during Jan. 21 sales and earnings call with analysts. Worldwide skin care sales jumped 18.2% in the fourth quarter to $383 mil. compared to the year-ago period, while full year sales grew 12.7% to $1.57 bil., J&J says. Neutrogena, Aveeno and Clean & Clear remain drivers of skin care growth, firm notes. U.S. skin care sales rose 16.4% to $170 mil. in Q4, and for the year, domestic sales were up 11.6% to $778 mil., firm states. Worldwide baby and kids care sales grew 4% to $285 mil. in the fourth quarter and were up 2.6% to $1.16 bil. for the year. Consolidated sales advanced 14.3% to $9.4 bil. in Q4 and net earnings reached $1.44 bil., according to J&J's 1sales and earnings release...
You may also be interested in...
Chattem Gold Bond, pHisoderm Extensions To Launch In Coming Months
Chattem is gearing up to launch a slew of new product line extensions within the next few months as its decision to increase its investment in R&D over the past two years begins to pay dividends
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program